HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Myeloma News

The HealthTree News for Myeloma is a place to learn all about Myeloma in easy-to-understand language. The site features news articles, patient stories, Myeloma basics articles, and clinical trial updates with new content every week.

ASCO 2023: A New Bi-Specific Therapy Combination for Relapsed or Refractory Myeloma Patients

Jun. 08, 2023

ASCO 2023: A New Bi-Specific Therapy Combination for Relapsed or Refractory Myeloma Patients

ASCO 2023: Comparing BLENREP (belantamab-mafodotin) to POMALYST (pomalidomide) and dex

Jun. 08, 2023

ASCO 2023: Comparing BLENREP (belantamab-mafodotin) to POMALYST (pomalidomide) and dex

ASCO 2023: The Ground-Breaking Combination of Two Bi-specific Antibody Therapies

Jun. 07, 2023

ASCO 2023: The Ground-Breaking Combination of Two Bi-specific Antibody Therapies

ASCO 2023: A New BCMA-Targeting Bi-specific Antibody, Linvoseltamab

Jun. 07, 2023

ASCO 2023: A New BCMA-Targeting Bi-specific Antibody, Linvoseltamab

ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma

Jun. 06, 2023

ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma

ASCO 2023: The New T-Charged CAR on the Block: PHE885

Jun. 06, 2023

ASCO 2023: The New T-Charged CAR on the Block: PHE885

ASCO 2023: A Maintenance Regimen for High-Risk Myeloma

Jun. 05, 2023

ASCO 2023: A Maintenance Regimen for High-Risk Myeloma

ASCO 2023: Benefits of Exercise for Multiple Myeloma Patients

Jun. 05, 2023

ASCO 2023: Benefits of Exercise for Multiple Myeloma Patients

Understanding the 2023 ASCO Annual Meeting: What Do Patients Need to Know?

Jun. 03, 2023

Understanding the 2023 ASCO Annual Meeting: What Do Patients Need to Know?

Understanding Patient Perspectives Toward Participation in Multiple Myeloma Clinical Trials

Jun. 01, 2023

Understanding Patient Perspectives Toward Participation in Multiple Myeloma Clinical Trials

HealthTree Coach Creates a Myeloma Game Plan

Jun. 01, 2023

HealthTree Coach Creates a Myeloma Game Plan

A New Bi-Specific Antibody Therapy On The Horizon: ABBV-383

Jun. 01, 2023

A New Bi-Specific Antibody Therapy On The Horizon: ABBV-383

Recent Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube